Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Isowater is a Canadian life sciences company that specializes in the supply and management of deuterium oxide (heavy water) for global markets. The company serves as a critical supplier for the pharmaceutical industry, particularly in the development of deuterated drugs, which utilize deuterium to improve the metabolic stability and safety profiles of small molecule therapeutics. Beyond drug development, Isowater provides deuterium for use in diagnostics, fiber optics, semiconductors, and scientific research. The company focuses on securing a stable, long-term supply chain for deuterium to support the growing demand in the life sciences and high-technology sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Isowater.